ROPC.S (ROPC.S) News
Track canonical SquawkNews coverage tagged to ROPC.S, ROPC.S. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
BRIEF — CHMP Recommends EU Approval Of Roche's Ocrevus For Children And Adolescents
Sept 18 (Reuters) — Roche Holding AG: Chmp Recommends Eu Approval Of Roche’s Ocrevus For Children And Adolescents With Relapsing Multiple Sclerosis Roche Holding Ag - Ema Chmp Recommends Approval Of Ocrevus Iv For Paedia
NEWS | Sep 18, 2026, 10:47 AM UTC
L
EMA panel backs EU approval of Roche’s Ocrevus for pediatric relapsing MS patients 10+
EMA’s CHMP recommended EU approval of Roche’s Ocrevus IV for relapsing multiple sclerosis in patients aged 10 and older. European Commission decision expected soon; FDA cleared the pediatric use in May 2026. Phase III OP
REGULATION | Sep 18, 2026, 10:47 AM UTC